During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...

This article reviews the current literature related to the treatment of COPD exacerbations and examines whether these data support current treatment guidelines.

COPD has no cure. Medication and treatment may help slow the progression ... Healthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and ...

Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

Seniors are a growing and increasingly prosperous demographic. As the senior population increases, a greater emphasis must be placed on keeping aging individuals healthy. Wellness checks are important ...

Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is ...

A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...

Breathing is essential for life, yet for many individuals suffering from chronic respiratory issues such as asthma and COPD, ...

Shobha ShuklaDespite being the most populous district of Himalayan state of Himachal Pradesh in India, Kangra has also led from the front in caring for the largest number of people with TB in the ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.